847 related articles for article (PubMed ID: 27714465)
1. IgA nephropathy with presentation of nephrotic syndrome at onset in children.
Shima Y; Nakanishi K; Sato M; Hama T; Mukaiyama H; Togawa H; Tanaka R; Nozu K; Sako M; Iijima K; Suzuki H; Yoshikawa N
Pediatr Nephrol; 2017 Mar; 32(3):457-465. PubMed ID: 27714465
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of massive proteinuria in primary IgA nephropathy with and without nephrotic syndrome: a single center cohort study.
Hu Y; Huang Z; Cao Q; Chen B; Xu S; Qiu W; You X; Zhang J; Chen C
Ren Fail; 2023; 45(2):2267138. PubMed ID: 37850851
[TBL] [Abstract][Full Text] [Related]
4. Crescentic IgA nephropathy in children.
Shima Y; Nakanishi K; Hama T; Mukaiyama H; Sato M; Tanaka Y; Tanaka R; Kaito H; Nozu K; Sako M; Iijima K; Yoshikawa N
Pediatr Nephrol; 2020 Jun; 35(6):1005-1014. PubMed ID: 31993782
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and outcomes of IgA nephropathy with nephrotic syndrome.
Kim JK; Kim JH; Lee SC; Kang EW; Chang TI; Moon SJ; Yoon SY; Yoo TH; Kang SW; Choi KH; Han DS; Kie JH; Lim BJ; Jeong HJ; Han SH
Clin J Am Soc Nephrol; 2012 Mar; 7(3):427-36. PubMed ID: 22223610
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous remission of nephrotic syndrome in patients with IgA nephropathy.
Han SH; Kang EW; Park JK; Kie JH; Han DS; Kang SW
Nephrol Dial Transplant; 2011 May; 26(5):1570-5. PubMed ID: 20841490
[TBL] [Abstract][Full Text] [Related]
7. Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome.
Han X; Xiao Y; Tang Y; Zheng X; Anwar M; Qin W
Clin Exp Med; 2019 Nov; 19(4):479-486. PubMed ID: 31542837
[TBL] [Abstract][Full Text] [Related]
8. IgA nephropathy (IgAN) presenting with the nephrotic syndrome.
Oviasu E
Trop Geogr Med; 1992 Oct; 44(4):365-8. PubMed ID: 1295149
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of childhood IgA nephropathy with minimal proteinuria.
Higa A; Shima Y; Hama T; Sato M; Mukaiyama H; Togawa H; Tanaka R; Nozu K; Sako M; Iijima K; Nakanishi K; Yoshikawa N
Pediatr Nephrol; 2015 Dec; 30(12):2121-7. PubMed ID: 26238276
[TBL] [Abstract][Full Text] [Related]
10. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.
Fabiano RCG; Araújo SA; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
J Pediatr (Rio J); 2017; 93(4):389-397. PubMed ID: 28130969
[TBL] [Abstract][Full Text] [Related]
11. Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.
Bagchi S; Singh G; Yadav R; Kalaivani M; Mahajan S; Bhowmik D; Dinda A; Agarwal SK
Ren Fail; 2016; 38(3):431-6. PubMed ID: 26837482
[TBL] [Abstract][Full Text] [Related]
12. Comparison between outcomes of IgA nephropathy with nephrotic-range proteinuria and nephrotic syndrome: do podocytes play a role?
Chen Y; Yang A; Hou Y; Liu L; Lin J; Huang X; Li J; Liu X; Lu F; Lin Q; Yang H; Yue S; Jiang S; Wang L; Zou C
Ren Fail; 2022 Dec; 44(1):1443-1453. PubMed ID: 36017686
[TBL] [Abstract][Full Text] [Related]
13. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
14. The difference between patients with nephrotic syndrome and nephrotic-range proteinuria in IgA nephropathy: a propensity score matched cohort study.
Li H; Wang F; Jia J; Yan T; Liu Y; Lin S
BMC Nephrol; 2022 Apr; 23(1):163. PubMed ID: 35488221
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
Yagi K; Okada M; Yanagida H; Kuwajima H; Ikeda M; Sugimoto K; Takemura T
Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
[TBL] [Abstract][Full Text] [Related]
16. Treatment and outcome of IgA nephropathy in children from one single center experience.
Mao Y; Zhou W; Zhou Z; Zhang C; Shen J; Yin L
BMC Pediatr; 2023 Jul; 23(1):377. PubMed ID: 37495962
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease.
Qin J; Yang Q; Tang X; Chen W; Li Z; Mao H; Jiang Z; Huang F; Yu X
Clin Nephrol; 2013 Jan; 79(1):37-44. PubMed ID: 22948116
[TBL] [Abstract][Full Text] [Related]
18. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of concomitant nephrotic IgA nephropathy and minimal change disease in children.
Shen H; Gu W; Mao J; Zhu X; Jin X; Fu H; Liu A; Shu Q; Du L
Nephron; 2015; 130(1):21-8. PubMed ID: 25924689
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and pathological analysis of IgA nephropathy with acute kidney injury].
Chen MG; Ye XH; Liang HY; Yang Q
Zhonghua Er Ke Za Zhi; 2016 Aug; 54(8):610-3. PubMed ID: 27510875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
